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Abstract: The COVID-19 pandemic has forced all nations to take an active role in infection 
control incorporating recommendations and measures to control viral dissemination. The 
epidemiological impact is very diverse and dynamic, even within the same region. Scientific 
knowledge regarding SARS-CoV-2 continues to improve every day with protocols needing 
to be updated and adjusted on a regular basis. Ophthalmology is a medical specialty 
identified to be at high risk for several reasons: it has very close doctor-patient contact, the 
virus has been detected in tears, and the ocular surface serves as a gateway to developing the 
infection. We have reviewed the current information on SARS-CoV-2 in the ophthalmologic 
field and provide up-to-date recommendations to help create protocols that can adapt to the 
dynamic situation of ophthalmologic institutions, patient cases, economic situations and 
access to diagnostic tests. This paper outlines the main recommendations regarding the 
initial consultation and outpatient clinics, measures to apply in the operating room (OR), 
and suggestions for post-surgical controls. Triage, according to the patient’s conditions and 
eye pathology, reduction of the time the patient is at the institution, social distancing, correct 
use of personal protective equipment (PPE), barrier methods, hygiene, as well as other 
recommendations mentioned in this document, will allow physicians to take care of the 
visual health of the patients while reducing the impact of the COVID-19 pandemic. 
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Introduction
The world is about to reach 1 year dealing with the COVID-19 pandemic, offering 
a mixed picture, with countries that are dealing with the second wave of this 
disease, some are just getting out of the first wave, while a minor sector is still 
waiting for the hit after travelling restrictions quit.
The future in the medium term is promising with hundreds of vaccines under 
research, with a few already in phase 3 accounting for over 90% of efficacy. In the 
short term, this pandemic is still forcing all nations to take an active role in 
infection control incorporating recommendations and measures to limit economic, 
social and health consequences related to the virus.
Some patients with ophthalmic pathologies (urgent and chronic) still postpone 
consultations, occasionally due to risk factors for COVID-19, but most frequently 
because of lack of information and fear of being exposed to the virus.
Correspondence: Juan Pablo Salica  
Consejo Argentino de Oftalmología, Tte. 
Gral. Juan D. Perón 1479, PB. Zip Code 
C1037ACA, Ciudad de Buenos Aires, 
Argentina  
Email jp.salica@gmail.com
submit your manuscript | www.dovepress.com Clinical Ophthalmology 2021:15 261–278                                                                       261
http://doi.org/10.2147/OPTH.S283327 
DovePress © 2021 Salica et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. 
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the 
work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Clinical Ophthalmology                                                                        Dovepress
open access to scientific and medical research































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Ophthalmologists, on the other side, evidence the con-
sequences of the absence of appropriate follow-ups and 
consultations as well as the updated descriptions of the 
impact of SARS-CoV-2 and the new lifestyle on visual 
health.
In this review, we examine the latest recommendations 
and main challenges in the ophthalmic field to reduce 
COVID-19’s impact learnt during the first year of the 
pandemic, to be applied at the present time or to future 
waves. Recommendations might be useful for other viral 
pandemics in the future.
Methods
A comprehensive review of the literature was carried out 
through PubMed beginning in April 2020. This search was 
conducted on regular basis due to a large number of 
articles being published. The amount of new information 
published in the short window shows the importance of 
this topic to health professionals, health systems, and 
government decision-makers.
The following PubMed terms in diverse combinations 
were used to search for related articles in this review: 
SARS-CoV-2, COVID-19, transmission, risk factors, eye, 
ophthalmology, ophthalmologist, surgery, operating room, 
conjunctivitis, personal protective equipment (PPE). 
A subsequent search was conducted when the terms were 
relevant. Publications cited in the articles selected by the 
search were also retrieved. Furthermore, special links 
related to COVID-19 on the National Center for 
Biotechnology Information (NCBI) site were checked, as 
well as public health information from the Centers for 
Disease Control and Prevention (CDC) and the National 
Institute of Health (NIH). Also, the World Health 
Organization (WHO) site was consulted. Previous to the 
publication’s date there were no restrictions applied.
COVID-19 Pandemic
Coronavirus is a family of enveloped positive-sense, sin-
gle-stranded RNA viruses associated with a range of diges-
tive and respiratory diseases: common cold, bronchitis, 
bronchiolitis and mild to severe pneumonia. Two members 
of this family have caused epidemic disease in the past: 
Middle East Respiratory Syndrome-related Coronavirus 
(MERS-CoV) and Severe Acute Respiratory Syndrome 
Coronavirus (SARS-CoV).1
SARS-CoV-2 (Severe Acute Respiratory Syndrome 
Coronavirus 2) is the name that the World Health 
Organization (WHO) assigned to a novel coronavirus 
responsible for the outbreak of COVID-19 (Coronavirus 
Disease 2019) in Wuhan city, province of Hubei, China on 
31 December 2019.1 One month later, the Emergency 
Committee of the WHO declared the disease outbreak 
a Public Health Emergency of International Concern.2
COVID-19 has a global impact due to its rapid viral 
spread aided by an international travel sector, which has led 
to even more rapid dissemination of the disease and to the 
health system’s collapse, even of those that were thought to 
be robust.3 Up to now, counting with treatments without 
demonstrated efficacy and some promising vaccines currently 
in phase 3 of clinical trials to limit the COVID-19 pandemic, 
a preventative strategy focused on proper epidemiologic mea-
sures and maximizing infection control are warranted.4
In order to develop a program to control and prevent the 
spread of the disease in healthcare facilities, it is important to 
understand the various ways in which pathogens are trans-
mitted: through direct contact, fomites, oral (ingestion), vec-
torborne, and droplets (respiratory droplets: >5 to 10 um, and 
airborne or droplets nuclei: <5 um).5 Airborne droplets may 
remain in the air for long periods of time and be transmitted 
to others over distances greater than one meter.6
The main vehicle for the transmission of SARS-CoV-2 is 
respiratory droplets and direct contact.7 The mechanism of 
SARS-CoV-2 is presumed to infect the human cells by spike 
glycoprotein binding to its cellular receptor, angiotensin- 
converting enzyme 2 (ACE2). Thus, the main virus entry 
occurs through nose, mouth and eyes cells that have the 
ACE2.8–10
Even though there is evidence of viral shedding in the 
excreta of COVID-19 patients, currently, there are no 
reports of faecal−oral transmission.11 Similarly, there is 
no evidence that SARS-CoV-2 undergoes intrauterine or 
transplacental transmission, but some recent case reports 
have suggested this might be possible.12
Cross-sectional and experimental studies indicate that 
the virus can remain viable and infectious for hours or 
even days depending on the material where the inoculum 
is placed.13–15
In the context of COVID-19, to protect patients and 
health care providers, infection control has to focus on direct 
contact, and the airborne droplet transmission in ophthal-
mology may be possible in specific circumstances and set-
tings in which aerosolizing procedures are performed.16
SARS-CoV-2 and Eye
The human ocular surface epithelium provides an addi-
tional entry portal for SARS-CoV-2.17,18 In fact, there are 
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some reports that indicate that the eyes were the suspected 
gateway for the virus.10,19
Several studies have documented the presence of 
SARS-CoV-2 genetic material on the ocular surface 
which was detected in conjunctival swabs and tears after 
performing a reverse-transcription polymerase chain reac-
tion (RT-PCR) assay for the detection of viral RNA in 
COVID-19 positive patients. A meta-analysis showed that 
this situation is still controversial and not very frequent, 
with estimated positive swabs in 1.95% of the cases (95% 
C.I. 0.74 to 4.11).20–22 At the moment of analysing the 
reason for this low percentage, one has to consider the 
effect of broad-spectrum antivirals in topical ophthalmic 
medications, a fact not reported in most publications.23
Viral RNA of SARS-CoV-2 was also detected in the 
retina of COVID-19 patients.24 Also, in a cross-sectional 
study, retinal and vasculature alterations were detected cor-
relating with COVID-19 disease severity in 54 patients.25 
Recent evidence demonstrated the presence of SARS-CoV-2 
in the vitreous and cornea, highlighting the criticality of 
donor screening guidelines and the plausibility of human 
eye tissue or eye fluids to be a source of infection.24,26
The ocular manifestations of COVID-19 include 
mainly signs and symptoms compatible with follicular 
conjunctivitis. The incidence of conjunctivitis is estimated 
around 1% to 3% and is related in a meta-analysis to more 
severe forms of COVID-19.20,27 Few articles have 
reported keratoconjunctivitis as the first symptom of 
COVID-19.28,29
Findings on the retina of COVID-19 positive patients 
include cotton wool spots and microhemorrhage at fundus 
examination. OCT findings were hyperreflective lesions at 
the level of ganglion cell and inner plexiform layers more 
prominently at the papillomacular bundle in both eyes. 
Results of OCT-angiography and ganglion cells complex 
analysis appeared normal.30
Some authors reported an increase in dry eye syndrome 
symptoms along with this pandemic. This might be due to 
a double mechanism: the mass use of face mask (incorrect 
fitting of the mask could disperse air around the eyes) and the 
increase in exposure to computer screens and cell phones 
(prolonged blinking intervals).31 Another finding, suspected 
as a possible COVID-19 repercussion, is the Sanitizer aero-
sol-driven ocular surface disease (SADOSD).32
SARS-CoV-2 and Eye Care
At the beginning of the COVID-19 pandemic, the initial 
recommendation the population heard was: “stay at 
home”. This was strongly remarked for elderly people 
and especially with comorbidities. Scientific associations 
communicate to postpone non-essential outpatient visits 
and elective surgical procedures. Soon expert panels 
defined what should be considered urgent to take care of, 
and once protocols were applied to control viral dissemi-
nation, eye care institutions reopened making a big effort 
to work in the new normal.
There was an evident delay in visits to the eye doctor, 
which still persists, turning acute and chronic pathologies 
to be misattended. This is frequent in patients with risk 
factors, due to fear and lack of correct information. At the 
top rank of eye, pathologies are diabetic retinopathy, glau-
coma and maculopathies. As we all know, they are sight- 
threatening diseases that may have a devastating impact. 
Patients and ophthalmologists are witnessing this trend 
that needs to revert; otherwise, this process could lead to 
a dramatic increase in disability, with an increase in social 
and government costs.33,34
Outpatient Clinic and General 
Presurgical Consideration
Consideration in the Outpatient Clinic
Measures to lower the risk of exposure to SARS-CoV-2 
should be bidirectional, they aim to take care of the 
patients and the staff.35
To plan a first contact with the patient in a remote way, 
promoting telephone consultation and/or telemedicine 
care, might be the most logical way to start. It is favour-
able to 1) give instructions about the visit,36 2) make 
a triage, 3) advance with interrogation, and to reduce the 
time of the visit.
A triage aims to detect possible cases of COVID-19 
and refer them to receive specialized attention, to differ the 
consultation whenever possible, to solve the patient’s pro-
blem via telemedicine care, and to define the circuit the 
patient should go for the personal consultation37 
(Figure 1).
It may be useful to give informed consent to the patient 
before the appointment. It should be adapted to local law 
and it should basically inform the patient about the risks 
during the pandemic, while at the same time, it may serve 
as a written declaration of symptoms compatible with 
COVID-19 or of contact with confirmed cases.38
Appointments should be organized in such a way that 
the patients do not overlap in common areas. The patient 
should be indicated to come alone or explained that their 
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companion should wait outside the facility if possible. It is 
also good to remind them to use a mask and eye 
protection.39–41 Once the patient arrives, triage should be 
repeated. Provide alcohol-based hand sanitizer.42
Once the patient enters the examination room, the 
ophthalmologist should wear PPE according to the expo-
sure planned. It is not common that ophthalmologists per-
form aerosol-generating procedures at the praxis. The risk 
Figure 1 Suggested flow-chart to deliver ophthalmologic assistance during COVID-19 pandemic.
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comes mainly because of the very close working distance 
between doctor and patient and when getting in touch with 
the mucosae, ocular secretions, and tears. For a safe work-
ing environment, it is important to train the healthcare 
team in the proper use of PPE.43,44
PPE Considerations in Ophthalmology
Respiratory Protection
There is consensus that the use of N95 respirators and face 
masks is indicated when facing patients who are COVID- 
19 positive or suspected to be infected during the aerosol- 
generating procedure.17,38,45–48
Nevertheless, during a simulated clinical activity, air-
borne aerosol generation was evidenced during speech and 
sneezing. N95 respirators mitigated airborne aerosol trans-
mission while standard surgical masks did not.49 Given 
this evidence, N95 respirators would provide physicians 
and healthcare workers with major protection.
When the supply of N95 respirators is short, they 
should be kept for high-risk use and aerosol-generating 
procedures only.22 Evaluate contingency measures for 
reprocessing N95.50–52 The National Institute for 
Occupational Safety and Health (NIOSH) published 
a recommended guidance for extended use and limited 
reuse of N95 filtering facepiece respirators in healthcare 
settings, which emphasizes there is no determined limited 
time of use when a shortage of supplies.
Eye Protection
When close contact is required, eye protection equipment 
should be used as part of a full PPE.39 Goggles should be 
worn for aerosolizing procedures, while glasses with an 
enveloping design may be easier to wear at the consultation.
Hand Protection
One of the most important prevention methods is hand 
hygiene.53 Alcohol-based formulations proposed by the 
World Health Organization (WHO) are proved to be 
highly efficient.42 The use of gloves is important when 
having direct contact with the patient. Gloves are subject 
to single-use. Ensure their removal does not cause addi-
tional contamination of hands.17
Body Protection
The physicians should protect their personal clothes with 
a white coat, disposable fluid repellent coveralls, or long- 
sleeved disposable fluid repellent gowns. These last two 
options will be required for aerosol-generating procedures.
The clothing can be worn for a single session. This 
means it should be changed every time that a health 
worker leaves a specific clinical care setting or exposure 
environment.17
Eye Examination Considerations to 
Reduce Viral Transmission
● Breath shields or slit lamp barriers are a must at this 
moment.37
● When testing for visual acuity, a phoropter is easier 
to sanitize.
● A hypoallergenic tape can be placed on the nose bridge 
of the surgical mask or cloth mask of the patient, to 
avoid blurring of the glasses with breathing vapour. 
This may be useful as well for other proceedings.
● Binocular indirect ophthalmoscope delivery system 
is preferred for fundus examination at the slit lamp.
● Determine intraocular pressure only when necessary 
in this transition time of the pandemic. Disposable 
tonometry devices are preferred. Avoid non-contact 
“air-puff” tonometry, since it generates aerosol.54 
Perkins tonometer use is also discouraged since it 
requires extremely close working distance. The use 
of alcohol 70% should be effective at disinfecting 
tonometer tips from SARS-CoV-2, always remem-
bering it would not be enough to inactivate adeno-
virus. In this last case, sodium hypochlorite dilution 
would be effective.
● Keep communication between patients and physician 
as minimum as possible during the visit. Avoid talk-
ing during a close examination.55
● Strive to perform all the studies needed during the 
same visit.
● When multidose eye drops are required, evaluate frac-
tioning for daily disposal. Try not to touch the ocular 
surface nor the eyelashes with the tip of the eye drop 
bottle at the moment of instilling it as it should be.56
● Disinfect your hands after having any contact with 
the patient.
● Take notice of the instruments and medications’ pla-
cement in the consulting room, avoid their contam-
ination and any source of transmission.
● Try to reduce ophthalmic diagnostic testing mainly 
when they will not change treatment criteria.
● Companies are developing and already offering 
ophthalmic equipment with a remote command to 
preserve social distancing.
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● Manufacturers are providing guidance on their web-
sites on the disinfection process of specific 
equipment.57
General Considerations for 
Ophthalmologic Institutions
Ophthalmologist and ophthalmic administrators should 
introduce structural and organizational changes to their 
institutions (Table 1).
Defining Cases, Triage and 
Screening Process
Defining Criteria for Appropriate Surgical 
Cases
The crucial step is to define the epidemiological situation the 
ophthalmic institution is immersed in, and its real capacity to 
handle urgent or elective surgeries in this pandemic.
In order to create a formal frame to list urgencies that 
should be attended, the Argentinean Council of 
Ophthalmology created a consensus by an expert panel, 
conformed by representatives of each ophthalmic subspe-
cialties societies of Argentina, the Committee for 
Prevention of Ocular Infections and the Chairs of the 
Ophthalmology Department of all the Universities of 
Argentina.61 In its turn, different societies worldwide 
gave similar suggestions.62 It is important to highlight 
that the medical criteria to decide what case should be 
operated on will always be fundamental.
Before performing eye surgery for a given case, the 
ophthalmologist has to consider and evaluate risks and 
benefits very thoroughly. As stated by the Centers for 
Disease Control and Prevention, USA (CDC), people at 
a higher risk are older adults (with 65 years old or above) 
and people with underlying medical conditions (such as 
chronic lung disease or moderate to severe asthma, 
a serious heart condition, severe obesity, diabetes, chronic 
kidney disease undergoing dialysis, liver disease and those 
immunocompromised). Every mentioned situation could 
represent serious disadvantages when performing 
surgery.63,64
A retrospective study on patients that developed 
COVID-19 pneumonia shortly after general surgery were 
older, more likely to have underlying comorbidities and 
underwent more difficult surgeries.64 This impact was not 
studied on ophthalmic operated patients, ocular surgery 
should not have the same negative repercussions on 
COVID-19 evolution, since it does not have an important 
hemodynamic impact, the area of compromised tissue is 
small and anaesthesia is usually done locally.
In this pandemic context, surgeries have been curtailed 
to preserve resources to face special medical needs raised 
by COVID-19. Elective surgery could be understood as 
optional in this scenario. Nevertheless, if surgery was 
consent between the patient and the physician, except 
limited cases, has implicit an important rationale backing- 
up the indication. If the pandemic prolongs, the elective 
surgeries need to come to the agenda (Table 2).





Institution ● It is wise to have two different clear circuits. One 
for patients who have tested negative for COVID- 
19 and one for patients with symptoms or sus-
pected epidemiological background positive to 
COVID-19.
● Use a signalling system to indicate circulation, 
where people should stand, where they should 
sit, to remind them to keep social distancing.58,59
● Make sure to install desks and countertop barriers 
for employee protection.
● As a way to reduce the use of PPE and avoid viral 
transmission, physical barriers, such as acrylic or 
glass windows, could be installed.60
● Ensure adequate ventilation and air exchange in all 
areas. High-efficiency particulate air (HEPA) filters 
in air conditioning systems will reduce the possi-
ble dissemination of the virus.
● Reduce unnecessary objects on surfaces to facil-
itate the cleaning and disinfection process.
● Implement the digital signature in as many pro-
cesses as possible (eg at the registration desk, in 
informed consents, prescriptions, and medical 
records).
Staff ● The staff could be divided into two or more 
teams, avoiding contact between them, to reduce 
chances of interpersonal dissemination of the 
virus.
● Protect all the staff that may be at higher risk for 
COVID-19. (Assign roles that are out of expo-
sure: telemedicine, counselling, writing, research, 
etc.).
● Contemplate the introduction of infection control 
by checking temperature and symptoms to staff 
daily.
● Assign inspection roles. Check and recheck pro-
cesses and implementation of protective 
measures.
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A group of the University of Chicago Medicine and 
Biological Sciences proposed a scoring system to ethically 
and efficiently manage resource scarcity and provider risk 
during the COVID-19 pandemic called Medically 
Necessary, Time-Sensitive Procedures (MeNTS). They 
considered 21 factors divided into three main areas: pro-
cedure factors, disease factors and patient factors. This 
system offers an objective way to ponder the indication 
of surgery. It helps to consider the major variables that 
may have an impact on the risk of the surgery.65
The Spanish Association of Surgeons published 
a dynamic scale of five possible scenarios/alerts that take 
into account the percentage of beds occupied by COVID-19 
patients in ICU, the compromise of resources, and the surgi-
cal procedures that should be performed.66 Taking this scale 
into account and adapting these criteria to ophthalmology, we 
could plan our surgical indications in five different scenarios 
given mainly by the curve of the infection and its direct 
relationship to the percentage of ICU occupancy (Table 3).
Along stages 1 to 4, ophthalmologists should always con-
sider proceeding with promptness to operate in urgent cases. 
Close to scenario 5, it is interesting to have in mind that it may 
be important to increase the critical care capacity and, since 
elective surgeries are postponed, ORs and postanesthesia care 
units (PACUs) could be converted into ICUs.67
Preoperative Screening Process to Rule 
Out COVID-19
The main objective of making a COVID-19 screening is to 
avoid transmission of the illness along the surgical pro-
cess, to keep a circuit that is free of COVID-19 and to 
decrease risk in presymptomatic patients who could be 
operated while infected with SARS-CoV-2.
Since the beginning of the outbreak of the virus in 
Argentina, as well as in many other countries, the health 
system has had significant limitations of their diagnostic 
testing capabilities. Moreover, such limitations became 
much clearer when the restrictive criteria for testing control 
were removed by the CDC.68 Until today physicians are 
recommended to use their judgment for screening patients 
and setting up biosecurity protocols. For this matter, we have 
included a variety of screening methods reported in multiple 
publications stating their results and limitations.
The preoperative screening will vary depending on 
each facility’s capacities, its epidemiological context, the 
type of patient, and the availability of diagnostic tests.
Epidemiologic and Symptomatic Triage
This evaluation aims to identify patients who are highly 
suspected of SARS-CoV-2 infection, regardless of any 
diagnostic test results (Table 4).69,70
The evaluation is suggested to be made using teleme-
dicine within 72 h before the surgery. It should be repeated 
in person on the day of the surgery.
Another approach recommends to carry it out 14 days 
before the proceeding, recommending the patient to avoid 
exposure to possible sources of contamination in their 
community.71,72 Triage results should be included in the 
patient’s medical history.
Diagnostic Tests for Detection of SARS-CoV-2
Nasopharyngeal RT-PCR 
Real-time reverse-transcriptase polymerase chain reaction- 
based assays performed in a laboratory are the reference 
standard for COVID-19 diagnostics. There are protocols 
that include this exam as a routine previous to any ophthal-
mic surgical procedure.
It is the most reliable test that confirms active infection 
because it has a high specificity to detect the virus (low 
rate of false positive).
Nevertheless, its sensitivity is estimated to be 70%. 
This means a high rate of false negative.73 This estimate 
will be modified mainly by the chances of infection of the 
patient’s community (pretest probability) and the quality 
Table 2 Facts to Consider in the Decision-Making Process 





Institution ● Resource limitations (PPE, health workforce, OR 
necessity for other urgent procedures)
● COVID-19 transmission risk
● Ophthalmic Institution Only/General Hospital
● OR facility and installation
Patients ● Individual patient risks
● General anaesthesia necessity
● Case prone to complications
● Ocular disease
Time ● Duration of surgery
● Disadvantages of postponing operation in the sur-
gical outcome or disease process.
Surgery ● Postoperative complications and readmissions
● Assess the effectiveness of nonoperative treat-
ment options.
● Costs
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of the technique to collect the nasopharyngeal swab. RT- 
PCR can remain positive for as long as 3 weeks from the 
onset of the symptoms.74 A positive RT-PCR result repre-
sents only the detection of viral RNA and does not neces-
sarily indicate that the virus is viable.75
Diagnostic Tests for Detection of Antibodies Against 
SARS-CoV-2: IgM and IgG 
The tests that detect antibodies against SARS-CoV-2 are 
not the gold standard to diagnose an active infection. 
They are tools that help to know, still with an important 
degree of uncertainty, if the patient has been in contact 
with the virus and may give a notion of where the 
patient might be situated in the natural history of the 
disease.
These tests could give more information regarding the 
cases suspected to have the infection, with repeated negative 
PCR results. It was proved that this group of patients can 
increase the risk of nosocomial transmission.76 Negative 
results would not exclude SARS–CoV-2 infection.77
IgM represents the humoral immune reaction to the 
virus. The antibody detection is performed by the 
enzyme-linked immunosorbent assay (ELISA). 
Immunoreactivity begins around the first week of symp-
toms onset, it reaches a peak at week three, and it 
lowers at week four to five. IgG can be detected after 
the second week and remains positive for several 
months. It still needs to be clarified to what extent 
a positive IgG response confers resistance to reinfection 
with SARS-CoV-2 and for how long (Figure 2).78
Thoracic Imaging
Role of Thoracic Imaging in Preoperative Assessment 
With RT-PCR as a gold standard, chest computed 
Table 3 Comparative Chart: Different Possible Scenarios According to the Percentage of Intensive Care Unit Occupancy
Percentage of ICU 
Occupied by COVID-19 
Patients
< 5% 6 to 25% 26 to 50% 51 to 75% > 76%
Resources Not compromised Not compromised Generally compromised Compromised Very Compromised
Surgical Activity Complete, with 
caution
Reduced Limited to urgencies Limited to 
urgencies
Emergencies
Main indications Pathologies that 
compromise the 
quality of life
Limited to sight- 
threatening 
pathologies
Limited to sight- 
threatening pathologies
Limited to sight- 
threatening 
pathologies
Limited to life- 
threatening 
pathologies
Table 4 Facts to Inquire in the Triage Process During COVID-19 Pandemic
Triage Scenario 1 Scenario 2 Scenario 3 Scenario 4 Scenario 5
Assessed Variables
Clinical ● Presence of fever (>37,5ºC)
● Presence of respiratory symptoms: cough, shortness of breath




● Muscle or body aches
● Headache
● Sore throat
● Congestion or runny nose
● Nausea or vomiting
Epidemiological ● Close contact with a person known or suspected to have coronavirus. The patient has been in an area where ongoing COVID- 
19 transmission has been confirmed. The patient has ever been diagnosed with COVID-19 infection Date of diagnosis Time 
since recovery
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tomography (CT) has demonstrated good-to-excellent sensi-
tivity for detection of COVID-19 pulmonary infection in 
symptomatic patients (with values ranging from 56% to 
97%, reported in different series).60,79–81 However, thoracic 
imaging findings are nonspecific for COVID-19 infection 
and may be similar to those evidenced in other viral lung 
diseases.76,79,82–87
Despite the sensitivity levels of chest imaging, the CDC 
does not currently recommend to diagnose COVID-19. This 
health institute states that viral testing remains the only spe-
cific method of diagnosis. Confirmation with the viral test is 
required even if radiologic findings are suggestive of COVID- 
19 on radiograph or CT. Similarly, the American College of 
Radiology (ACR) has recently communicated CT should not 
be used to screen for or as a first-line test to diagnose COVID- 
19. CT should be used sparingly and reserved for hospitalized, 
symptomatic patients with specific clinical indications for 
CT.88 This statement contrasts with some guidelines that 
recommend chest X-rays as a preoperative exam.45
Taking into account the last considerations, among the 
difficulties we still encounter, the most important ones are 
the gaps that remain in screening asymptomatic persons 
during the incubation phase.77,89
The New Normal: Considerations to 
Perform an Elective Surgery on 
a Recovered COVID-19 Patient
In order to perform programmed eye surgery in a patient 
that had the infection, the advice of a specialist in COVID- 
19 should be followed since guidelines are frequently 
changing. Time since diagnosis and recovery should be 
confirmed to uphold the decision as to whether clearance 
testing is required or not.
Ideally, the patient should already be asymptomatic for 
more than 14 days and count with two negative PCRs 
results separated by 24 h.90 Additionally, IgM should be 
negative and IgG, already with detectable titles.
Operating Room Considerations
SARS-CoV-2 and Eye Surgical Procedures
During eye surgery, the main factors that may impact viral 
transmission are 1-procedures that have the potential to gen-
erate aerosol, 2-working distance between ophthalmologist 
and patient, 3-prolonged time of surgery, 4-air flow, and 
5-use of barrier methods and personal protective equip-
ment (PPE).
Figure 2 Chronological estimate of diagnostic test probability to detect SARS-CoV-2 in the COVID-19 natural history. Estimated time intervals should be considered 
approximations. Publications are not consistent with this information since many factors have a significant influence on the shift of the curves. 1-PCR indicates real-time 
polymerase chain reaction. 2-IgM, Immunoglobulin M. 3-IgG, Immunoglobulin G.
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Ophthalmic procedures and the potential to generate 





- Oculoplastic, orbit, strabismus, tumoral and nasola-
crimal duct surgery: Given that common ophthalmic pro-
cedures do not generate an important amount of aerosols, 
the main source of transmission continues to be the 
patient’s respiratory tract. During this transition of the 
COVID-19 pandemic, general anaesthesia should be 
replaced, if the case allows it, to avoid aerosolization 
during intubation.
- YAG and Argon laser: They are not supposed to 
produce aerosol patients that need to be treated with pan- 
photocoagulation; they are mostly diabetic and 
immunocompromised.
Considerations for Ophthalmological 
Surgical Procedures to Reduce Viral 
Transmission
Topical povidone-iodine use should be considered prior to 
any procedure to lower the risk of any unknown or uncer-
tain evidence of virus transmission.93
Standard surgical antisepsis using povidone-iodine 5% 
would reduce the viral load on the conjunctiva. Topical 
povidone-iodine is virucidal with in vitro testing of 0.23% 
povidone-iodine producing a 10,000-fold reduction in the 
viral load of SARS-CoV and MERS-CoV within 15 
seconds.94,95
Phacoemulsification Considerations and 
Aerosolization During Cataract Surgery
In the phacoemulsification procedure, the majority of the 
aqueous humour is visco-expressed before capsulorhexis 
which creates a replacement of the concerning infected 
intraocular fluid. Performing irrigation/aspiration for 
a minimum of 6 seconds prior to starting active phacoe-
mulsification will significantly decrease the proportion of 
any remaining intraocular fluid (and consequently any 
theoretical virus load) in any aerosol produced. As 
a result, the aerosolization created during phacoemulsifica-
tion is generated mainly from BSS (the surgery is per-
formed in a closed intraocular system which allows this 
dilution process to occur).91 Administrate hydroxypropyl 
methylcellulose 2% (HPMC) every minute during phacoe-
mulsification to coat the corneal surface, including the 
main incision. HPMC is a low viscosity and moderate 
viscoelastic compound, that acts as a barrier for aerosol 
formation and dispersion.96 A smaller incision size 
reduces aerosol leakage. This statement was noted in 
a comparison between a 2.75 mm tip with a 2.2 mm tip.97
Applying the measures mentioned above, the risk of 
aerosolized virus during phacoemulsification is expected 
to be greatly reduced.
Pars Plana Vitrectomy (PPV) and Other Posterior 
Segment Procedures
The PPV is expected to involve a low risk of virus trans-
mission due to the fact that it is performed in a closed 
surgical system with valved trocar cannulas. Aerosol gen-
erated during any procedure is expected to be contained 
within the eye. However, external cautery should be mini-
mized and performed with vigorous irrigation.93
The intravitreal injections procedure has no additional 
risk of transmission from the ocular surface. However, 
given that diabetic and elderly patients are at a higher 
risk for COVID-19 complications, it is important to con-
sider prioritizing those at the greatest risk of irreversible 
vision loss. The Royal College of Ophthalmologists has 
prepared guidance as a temporary response to the clinical 
management of patients during the ongoing COVID-19 
pandemic.98,99
Cautery-Related Procedures
Oculofacial plastics, pediatric ophthalmology, ocular sur-
face tumours and reconstruction.
Cautery implementation should be reduced to 
a minimum or avoided, if possible since it has been asso-
ciated with significant airborne particulate matter 
production.13 During cautery-related procedures, it is 
recommended to wear N95 masks or equivalent.13
One option to reduce cautery plume is to apply gener-
ous irrigation. Another option to consider is to perform 
active air suction right next to the area where coagulation 
is intended.
Pan-Photocoagulation Treatment
For this intervention, the physician should consider the 
recommendations given for eye examination. For instance, 
it is suggested the use of breath shield on a laser slit lamp, 
the hypoallergenic tape to secure the patient’s surgical 
mask on the nasal bridge, to avoid talking, and to use 
proper PPE (gloves, long sleeves gowns, and respirators, 
if available). Instilling a drop of iodopovidone 5% after 
proparacaine may be considered to reduce the possible 
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presence of virus on the eye surface. Panphotocoagulation 
contact lenses should be disinfected according to the man-
ufacturer’s recommendations. Washing the contact lenses 
with detergent and water proved to be effective to control 
viruses and bacteria as well as disinfecting them with 
bleach.100
General Considerations for the OR
Each institution should adapt the recommendations accord-
ing to its capabilities. It is important to critically evaluate if 
the institution can responsibly face the performance of the 
surgery of a suspected or confirmed COVID-19 patient. 
When it is not convenient to operate this type of patient in 
the institution, you should have the patient referral ready.
● Reduce personnel in the OR to the minimum needed.
● Assign an OR with different access for suspected or 
confirmed COVID-19 patients.82
● Assign OR and a defined circuit for patients who 
have tested negative for COVID-19.
● Reduce surfaces that can be contaminated. Leave inside 
the OR only what will be needed during the surgery.
● Prepare an area close to the OR, as a pre OR, to leave 
materials that could be necessary during the surgery.
● A separate cart could be useful to the circulating 
nurse to move equipment or carry drugs into the OR.
● Understanding the air-flow within the OR is crucial 
to minimizing the risk of infection.
○ OR will have negative pressure, the exchange rate 
of air lowers the viral shedding.101,102
○ A negative pressure environment could be created 
in a corner of the operating complex.82
○ It is recommended to use a HEPA filter.
○ If OR has not the appropriate filters, air condition-
ing should be off.
○ Maintain doors closed. Avoid opening and closing 
doors when not necessary.103
● The anteroom is used for donning/doffing of COVID- 
19 PPE.
● Consider fully recovering the patient in the same 
OR.82
Workflow
Try not to make significant changes in protocols for surgi-
cal procedures to avoid making new mistakes.
The time between patients requires proper planning to 
allow the new measures to be taken into consideration.
Patient Preparation
● Triage at arrival.
● Patient identification. Wristbands alert if a patient is 
COVID-19 suspicious.
● If the patient is COVID-19 positive/suspicious, trans-
fer to the OR should be done with the proper pre-
paration and coordination. Halls should be clear and 
be kept under surveillance by the security staff.
● Change patient
○ Provide patients with a gown, shoes, a cap, and 
a surgical mask.
○ Personal belongings can be placed in a plastic bag.
● Confirm the eye to be operated and mark it.
● Limit talking inside the OR.
Staff Assignments
Reduce the number of personnel and circulation within the 
operating room. It is important to plan the tasks to be 
carried out, the minimum necessary elements inside the 
OR and the assignment of roles. The training of all the 
members of the staff that work in the OR should be 
mandatory. It aims at avoiding cross-infection. If neces-
sary, the staff could be trained using simulation (Table 5).
OR Cleaning and Disinfection 
Considerations
Aerosol and surface stability of SARS-CoV-2 has been 
proven in multiple studies. The proper cleaning and disin-
fection in the OR are crucial for both patient and health-
care staff according to the procedures that were 
followed.14,106
Improve the organization in the OR to increase the 
frequency of cleaning and ensure a thorough cleaning. 
The time between surgeries will be compromised and 
should be scheduled accordingly.
These interventions require proper compliance. 
Evidence-based surveillance can be implemented optimiz-
ing sustainability.107
Considerations for the Cleaning Personnel
Health care workers’ training, practice, and observation for 
infection prevention are of great importance, as well as 
guidance on the type of PPE, and how the donning and 
doffing process should be made.53,107–109
Before entering the OR, air contamination should be 
addressed.13 A recent study showed a 3-hour persistence 
of SARS-CoV-2 in aerosols.14 High-frequency air change 
(15–25 per hour) can rapidly reduce aerosol particles.102
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When entering the OR after surgery of a COVID-19 
positive patient, the use of PPE is mandatory (face shield or 
goggles, N95 or higher respirator, isolation gown, a pair of 
non-sterile gloves).53
Disinfectant Solutions
Disinfectant solutions proven to eliminate the virus are 
sodium hypochlorite 0.21% (Figure 3), alcohol solutions 
at 70–95%, and hydrogen peroxide at 0.5%, glutaralde-
hyde 0.5–2.5%, formaldehyde 0.7–1% and quaternary 
ammonium.15,109–111 The specific disinfectant solution 
should be used as instructed by the manufacturer.
A simple approach consists in wet cleaning with two 
buckets: cleaning with detergent (10 ml of detergent 
diluted in 10 litres of warm water), then disinfecting all 
the surfaces with sodium hypochlorite at 0.5%.112
The cleaning sequence should remain the same. 
Decontaminate all surfaces, considering screens, keyboard, 
mouse, cables, monitors, and anaesthesia machines. For 
proper inactivation of the coronavirus, surfaces should be 
exposed to solutions for at least 1 minute.15
Some protocols consider the use of hydrogen peroxide 
vaporizers, UV-C lights and chlorine dioxide solution to 
decontaminate the OR. More evidence-based research 
should be done to adopt these recommendations.
Considerations After Surgery, 
Follow-Ups, and Complications
The same criteria used for previous processes should be 
applied here: reduce patient time spent at the institution 
and employ proper use of hygiene and barrier methods. 
For surgical patients, one needs to consider several factors 
before proceeding, such as anaesthesia, operating room 
workflow/staffing, and how nursing preoperative and post-
operative care will be managed. For example, if the patient 
requires close follow-up or may be at higher risk for 
postoperative complications, unless urgency or emergency, 
this surgical patient should be deferred so as not to make 
them run the unnecessary risk of contracting the virus with 
a potentially unfavourable outcome. Virtual visits: try to 
make follow-ups using telemedicine.
● Reduce the face-to-face visit rate.
● Provide the patient with written instructions and alarm 
symptoms, as well as ways of seeking medical assistance.
● The postoperative exam is hard to be replaced. 
However, if required, try to streamline the examina-
tion by testing what is essential and hold the rest of 
the consultation by phone or using telemedicine.
Proper documentation of the steps aimed at mitigating 
the transmission of the virus and keeping patients and staff 
Table 5 Staff Assignments in the Operating Room for an 
Ophthalmic Surgery During COVID-19 Pandemic
Member of the 
Surgical Team
Assignments in the Operating Room
Circulating Nurse ● Have a preoperational checklist
● In charge of bringing materials and instru-
ments into the OR as the surgery 
develops.
Surgical Assistant ● Properly plan the material that will enter 
the OR. Any unnecessary material will be 
assumed as contaminated and should be 
discarded.
Surgeon ● The operation should be led by an experi-
enced surgeon to minimize complications, 
risks, and time of exposure inside the OR.
● Avoid risky manoeuvres during surgery. 
Aim to perform safe surgeries.
● Contemplate those surgical approaches 
that have the lowest probability of post-
operative complications.
Anesthesiologist Since this is one of the most exposed 
specialities, generally anaesthetists have very 
clear protocols to follow to reduce 
aerosolization and extreme air 
contamination during urgent and elective 
surgeries.59
● Try to avoid general anaesthesia unless 
mandatory.
● Topical anaesthesia should be preferred to 
local anaesthesia whenever possible.
● The OR staff must not access the OR until 
the patient is intubated.
● N95 or OR PAPR (powered air-purifying 
respirator) must be used for all aerosol- 
generating procedures.
● If intubation is required for the surgery, 
recommend intubation in a negative pres-
sure room prior to OR, as well as extu-
bation. Consider using an aerosol box to 
reduce aerosolization in the OR.104,105
● Use an extra heat and moisture exchanger 
(HME) filter and viral filter on the expira-
tory limb of the anaesthesia machine 
circuit.105 Clamp endotracheal tube before 
any disconnection is planned.
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safe is prudent, safeguarding yourself and the institution 
against legal action. We encourage ophthalmologists to 
take special consideration not only to actively work on 
prevention but also to document proof of all the measures 
and special precautions taken. Thus, it is recommended 
that the medical record reflects good rationale as to why 
the patient was operated during this pandemic and that it 
includes the patient’s consent to the possibility of 
increased morbidity. During the COVID-19 pandemic, it 
is important to demonstrate that the institution has imple-
mented measures to avoid viral dissemination and has 
taken special care to address patients’ concerns.
The lack of adequate legal protection for surgeons 
seems to have an impact in some institutions, reducing 
the volume of surgical interventions during a pandemic era 
and the immediately following period. This needs to shift, 
in order to provide efficient health care to all patients.34
Discussion
In this review, we aim to provide information as well as 
several recommendations for ophthalmologists and health-
care institutions to better adapt to the new situation created 
by the COVID-19 pandemic.
First, regarding hospital triage: a reasonable approach 
to help standardize indications and preserve resources for 
more urgent cases according to ICU occupancy has been 
adapted following, in part, the proposals by the Spanish 
Association of Surgeons. Although this model has not yet 
been validated, its usefulness seems reasonable. In addi-
tion, we have outlined factors for the surgeon to keep in 
mind when judging surgical indications.
Second, the eye as a source of viral transmission: the 
presence of SARS-CoV-2 on the ocular surface and its 
infectious capacity is an obvious major concern in the 
ophthalmologic community. Although this remains 
controversial, it should soon be clarified by evidence. 
After writing this review, we realize that considering the 
eye as a source of viral dissemination for the ophthalmol-
ogist may not have the expected relevance. The reason for 
this is that tears and ocular secretions are body fluids we 
should always be aware of and not only during the 
COVID-19 pandemic. Taking the precautions mentioned 
above, the risk of transmission can be significantly low-
ered while providing care of ophthalmic patients. The 
focus of concern should continue to be the respiratory 
tract as the main source of viral spread.
Third, viral screening and testing: there are multiple 
approaches in the screening process to rule out COVID- 
19; up to now, they have shown to be expensive, extensive 
and non-conclusive. Significant work has gone into mak-
ing diagnostic tests more reliable and accessible. However, 
beyond this, given the possibility that a COVID-19 patient 
may not be detected by screening, precautions and protec-
tions should never be avoided.
Fourth, viral transmission: the airborne route of 
transmission is still controversial, and this explains the 
main differences in PPE recommendations. On the one 
hand, the World Health Organization recommends dro-
plet and contact precautions for those people caring for 
COVID-19 patients. Their argument is that airborne 
transmission remains unproven in clinical situations 
since it was not reported in the analysis of 75,465 
COVID-19 cases in China. Furthermore, airborne evi-
dence was studied in simulated conditions and was 
largely not peer-reviewed.
On the other hand, the US CDC and the European 
Centre for Disease Prevention and Control recommend 
airborne precautions for any situation involving the care 
of COVID-19 patients and consider the use of medical 
masks as an acceptable option in case of respirator 
Figure 3 Formula to dilute sodium hypochlorite at desired concentration.
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shortages. Moreover, it is unanimously recommended to 
use full protection for aerosol-generating procedures.
Fifth, following all the recommendations to take care 
of the health of patients and workforce at ophthalmic 
institutions becomes unproductive when 24-hour personal 
care is not taken.
Until the COVID-19 pandemic reaches its end, it is 
crucial to monitor new publications and recommendations, 
remaining flexible in order to actively make appropriate 
modifications during this pandemic.
Conclusion
When facing a viral pandemic, our suggestion is that 
a designated group or committee summarizes preferred 
practices and tailors them to the particular institution. 
They should take into account the epidemiologic context, 
the local regulations, the patient’s needs, the economic 
situation, the access to diagnostic tests, and the services 
offered.
Making a triage according to the patient’s conditions 
and eye pathology, reducing the time the patient is at the 
institution, keeping social distancing, accurately using per-
sonal protective equipment (PPE), placing barrier meth-
ods, taking care of hygiene, as well as following other 
recommendations mentioned in this review, will allow 
physicians to take care of the visual health of the patients 
while reducing the impact of the COVID-19 pandemic.
Disclaimer
The authors would like to declare that this document 
contains recommendations based on the best evidence 
found at the moment of writing, and also contains personal 
analysis considered important for ophthalmology.
This document does not have the intention to set 
a standard of care and cannot ensure a successful outcome 
in every situation. These guidelines aim to help adapt 
protocols according to the regional, local and individual 
hospital policies and expertise. New information regarding 
this topic may change the recommendations in this review 
in a significant way; and therefore, we cannot warrant the 
completeness of the guidance.
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